A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19
N. Martinelli+12 more
semanticscholar +1 more source
PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI™ healthcare database. [PDF]
Uriol-Rivera MG+8 more
europepmc +1 more source
Evaluating the potential for iodinated radiocontrast agents to interfere with ADAMTS13 activity testing via fluorescence resonance energy transfer methodology. [PDF]
Jacobs JW+8 more
europepmc +1 more source
Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor [PDF]
Masashi Akiyama+4 more
openalex +1 more source
Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia [PDF]
János Rigó+9 more
openalex +1 more source
Unraveling antibody-induced structural dynamics in the ADAMTS13 CUB1-2 domains via HDX-MS. [PDF]
Bonnez Q+8 more
europepmc +1 more source
A Comparison of Two Commercial ADAMTS13 Activity Assays With a Reference Laboratory Method [PDF]
Ronda A. Crist, George M. Rodgers
openalex +1 more source
Prospective Study of ADAMTS13 and von Willebrand Factor's Role in the Prediction of Outcomes in Acute Ischemic Stroke. [PDF]
Makris M+10 more
europepmc +1 more source
ADAM metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13); von Willebrand factor (VWF) [PDF]
openalex +1 more source